Monkey AIDS virus rebuilds itself

Brown, Phyllida
September 1994
New Scientist;9/17/94, Vol. 143 Issue 1943, p4
Reports on research by British scientists which shows that a retrovirus that causes AIDS in monkeys can revert from a weak to a virulent form within weeks by repairing a tiny fragment of missing genetic material. Researchers' concern over other scientists who are against developing AIDS vaccines based on live HIV which have been weakened by removing parts of its genome; Methodology used in the research.


Related Articles

  • Testing for AIDS.  // Commonweal;7/17/87, Vol. 114 Issue 13, p403 

    Editorial. In the search to halt, or at least retard, the spread of the AIDS retrovirus, a block has emerged between two opposing camps, sexuality and social change. Testing has already begun and the direction taken by federal policy is crucial. Poses some basic questions that need to be...

  • Renaming the AIDS Virus. Helquist, Michael // Advocate;8/19/86, Issue 453, p23 

    Reports on the International Committee for the Taxonomy of Viruses' selection of a new name for the retrovirus believed to cause AIDS.

  • A Human T-Lymphotropic Retrovirus (HTLV-III) as the Cause of the Acquired Immunodeficiency Syndrome. Gallo, Robert C.; Wong-Staal, Flossie // Annals of Internal Medicine;Nov85, Vol. 103 Issue 5, p679 

    Examines the virus that causes AIDS. Biological features of retroviruses; Structure of retroviral genomes; Morphology of the target cell of human retroviruses.

  • Infection by the Retrovirus Associated with the Acquired Immunodeficiency Syndrome. Levy, Jay A.; Kaminsky, Lawrence S.; Morrow, W.J.W.; Steimer, Kathelyn; Luciw, Paul; Dina, Dino; Hoxie, James; Oshiro, Lyndon // Annals of Internal Medicine;Nov85, Vol. 103 Issue 5, p694 

    Examines the retrovirus associated with AIDS. Isolation of associated retroviruses; Cytopathic changes in lymphocytes; Properties and structural features of retroviruses.

  • Retrovirus infections among patients treated in Britain with various clotting factors. Cheinsong-Popov, R.; Tedder, R.S.; O'Connor, T.; Clayden, S.; Smith, A.; Craske, J.; Weiss, R. // British Medical Journal (Clinical Research Edition);7/19/1986, Vol. 293 Issue 6540, p168 

    Examines the retrovirus infections among patients treated with clotting factors in Great Britain. Prevalence of viral infections in patients at risk for AIDS; Identification of the human T lymphotropic virus (HTLV) type; Failure of the HTLV to transmit blood products.

  • Updated HIV Treatment Recommendations for 2002.  // American Family Physician;12/1/2002, Vol. 66 Issue 11, p2159 

    Discusses the study 'Antiretroviral treatment for adult HIV infection in 2002. Updated recommendations of the International AIDS Society-USA Panel,' by P.G. Yeni et al., from the July 10, 2002 issue of the 'Journal of American Medical Association.'

  • The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Sheehy, Ann M.; Gaddis, Nathan C.; Malim, Michael H. // Nature Medicine;Nov2003, Vol. 9 Issue 11, p1404 

    The human protein apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like-3G (APOBEC3G), also known as CEM-15, mediates a newly described form of innate resistance to retroviral infection by catalyzing the deamination of deoxycytidine to deoxyuridine in viral cDNA replication...

  • Weight Gain, Improvement in Metabolic Profile, and CD4 Count with Insulin Administration in an AIDS Patient. Kabadi, Udaya M. // AIDS Patient Care & STDs;Nov2000, Vol. 14 Issue 11, p575 

    Assesses the effect of subcutaneous (S.C.) insulin administration in conjunction with antiretroviral drug therapy in a subject with AIDS. Limited success of anabolic agents utilized for retarding or preventing progressive wasting of patients; Marked improvements in patients treated with S.C....

  • Body Habitus Alterations in HIV-Infected Women Treated with Combined Antiretroviral Therapy. Ridolfo, Anna Lisa; Gervasoni, Cristina; Bini, Teresa; Galli, Massimo // AIDS Patient Care & STDs;Nov2000, Vol. 14 Issue 11, p595 

    Fat distribution alterations are among the most frequent and unexpected side effects of combined antiretroviral therapy. They may occur in patients receiving protease inhibitor-containing regimens and those treated with combinations of only nucleoside reverse transcriptase inhibitors. The broad...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics